NASDAQ : BBLG
Bone Biologics Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 0.37085 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 1.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 2.06M | 2.17M | 2.09M | 2.52M | 2.09M | 1.02M |
| Research & Development | 950.11K | 1.06M | 2.13M | 6.91M | 1.58M | 82.04K |
| Operating Expenses | 3.01M | 3.23M | 4.22M | 9.43M | 3.67M | 1.10M |
| Operating Income | -3.01M | -3.23M | -4.22M | -9.43M | -3.67M | -1.10M |
| Interest Expense | -731.71K | -805.11K | ||||
| Interest & Investment Income | 169.62K | 121.98K | 55.66K | 1.87K | ||
| Other Non Operating Income (Expenses) | 1.00K | 3.97K | 51.08K | 892.69K | 2.91M | |
| EBT Excluding Unusual Items | -2.84M | -3.11M | -4.11M | -8.53M | -1.48M | -1.91M |
| Legal Settlements | -414.99K | |||||
| Other Unusual Items | 297.50K | |||||
| Pretax Income | -2.84M | -3.11M | -4.11M | -8.95M | -1.48M | -1.61M |
| Net Income | -2.84M | -3.11M | -4.11M | -8.95M | -1.48M | -1.61M |
| Preferred Dividends & Other Adjustments | 3.21M | |||||
| Net Income to Common | -2.84M | -3.11M | -7.32M | -8.95M | -1.48M | -1.61M |
| Shares Outstanding (Basic) | 2.28M | 1.17M | 252.96K | 43.86K | ||
| Shares Outstanding (Diluted) | 2.28M | 1.17M | 252.96K | 43.86K | ||
| EPS (Basic) | -1.24 | -2.65 | -28.96 | -204.05 | ||
| EPS (Diluted) | -1.24 | -2.65 | -28.96 | -204.05 | ||
| Free Cash Flow | -2.57M | -2.69M | -4.12M | -9.56M | -3.57M | -1.23M |
| Free Cash Flow Per Share | -1.12 | -2.29 | -16.31 | -217.89 | ||
| EBIT | -3.01M | -3.23M | -4.22M | -9.43M | -3.67M | -1.10M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.09M | 5.33M | 3.33M | 3.03M | 7.54M | 6.68M |
| Cash & Short-Term Investments | 6.09M | 5.33M | 3.33M | 3.03M | 7.54M | 6.68M |
| Other Receivables | 8.98K | 9.89K | ||||
| Receivables | 8.98K | 9.89K | ||||
| Prepaid Expenses | 73.75K | 242.95K | 278.18K | 382.35K | 377.01K | |
| Other Current Assets | 261.64K | 208.97K | 258.06K | 328.84K | 579.91K | |
| Total Current Assets | 6.43M | 5.80M | 3.86M | 3.74M | 8.50M | 6.68M |
| Total Assets | 6.43M | 5.80M | 3.86M | 3.74M | 8.50M | 6.68M |
| Accounts Payable | 480.58K | 417.88K | 373.04K | 360.66K | 104.79K | 99.91K |
| Other Current Liabilities | 198.00 | 703.00 | 4.67K | 470.74K | 2.44M | |
| Total Current Liabilities | 480.77K | 418.59K | 377.71K | 831.40K | 2.55M | 99.91K |
| Total Liabilities | 480.77K | 418.59K | 377.71K | 831.40K | 2.55M | 99.91K |
| Common Stock | 3.39K | 1.79K | 492.00 | 534.00 | 64.00 | 10.35K |
| Additional Paid-In Capital | 96.24M | 93.51M | 88.50M | 83.81M | 77.91M | 77.04M |
| Retained Earnings | -90.29M | -88.13M | -85.02M | -80.91M | -71.96M | -70.48M |
| Shareholders' Equity | 5.95M | 5.38M | 3.48M | 2.91M | 5.95M | 6.58M |
| Total Liabilities & Equity | 6.43M | 5.80M | 3.86M | 3.74M | 8.50M | 6.68M |
| Net Cash (Debt) | 6.09M | 5.33M | 3.33M | 3.03M | 7.54M | 6.68M |
| Net Cash Per Share | 2.66 | 4.54 | 13.14 | 69.01 | ||
| Filing Date Shares Outstanding | 3.39M | 1.80M | 545.17K | 89.04K | 11.60K | |
| Total Common Shares Outstanding | 3.39M | 1.80M | 492.33K | 89.04K | 10.63K | |
| Working Capital | 5.95M | 5.38M | 3.48M | 2.91M | 5.95M | 6.58M |
| Book Value Per Share | 1.76 | 3.00 | 7.08 | 32.64 | 559.69 | |
| Tangible Book Value | 5.95M | 5.38M | 3.48M | 2.91M | 5.95M | 6.58M |
| Tangible Book Value Per Share | 1.76 | 3.00 | 7.08 | 32.64 | 559.69 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -2.84M | -3.11M | -4.11M | -8.95M | -1.48M | -1.61M |
| Stock-Based Compensation | 80.86K | 256.36K | 188.82K | 152.60K | 266.63K | 207.03K |
| Other Operating Activities | -1.00K | -3.97K | -51.08K | -892.69K | -2.18M | 495.55K |
| Change in Accounts Payable | 182.35K | 91.03K | 89.78K | 255.88K | 4.88K | -365.49K |
| Change in Unearned Revenue | -783.67K | 783.67K | ||||
| Change in Other Net Operating Assets | 10.02K | 74.42K | -240.03K | 660.72K | -956.92K | 45.00K |
| Operating Cash Flow | -2.57M | -2.69M | -4.12M | -9.56M | -3.57M | -1.23M |
| Long-Term Debt Issued | 1.06M | |||||
| Total Debt Issued | 1.06M | |||||
| Short-Term Debt Repaid | -10.61K | |||||
| Total Debt Repaid | -10.61K | |||||
| Net Debt Issued (Repaid) | 1.05M | |||||
| Issuance of Common Stock | 2.66M | 4.70M | 4.42M | 5.04M | 4.43M | 6.86M |
| Financing Cash Flow | 2.61M | 4.70M | 4.42M | 5.04M | 4.43M | 7.90M |
| Net Cash Flow | 39.00K | 2.01M | 298.56K | -4.51M | 862.95K | 6.68M |
| Free Cash Flow | -2.57M | -2.69M | -4.12M | -9.56M | -3.57M | -1.23M |
| Free Cash Flow Per Share | -1.12 | -2.29 | -16.31 | -217.89 | ||
| Levered Free Cash Flow | -1.70M | -1.65M | -2.73M | -7.21M | -990.33K | |
| Unlevered Free Cash Flow | -1.70M | -1.65M | -2.73M | -7.21M | -533.00K | |
| Cash Interest Paid | 12.06K | |||||
| Change in Working Capital | 192.37K | 165.45K | -150.25K | 132.92K | -168.37K | -320.49K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.26M | 2.60M | 2.32M | 2.41M | 3.21M | 36.43M |
| Enterprise Value | -4.83M | -3.45M | -1.25M | -2.04M | -1.85M | 49.19M |
| Last Close Price | 0.37 | 1.45 | 5.64 | 27.12 | 301.97 | 5,068.80 |
| PB Ratio | 0.21 | 0.48 | 0.67 | 0.83 | 0.54 | 5.54 |
| P/TBV Ratio | 0.21 | 0.48 | 0.67 | 0.83 | 0.54 | 5.54 |
| Net Debt / Equity Ratio | -1.02 | -0.99 | -0.95 | -1.04 | -1.27 | -1.01 |
| Net Debt / FCF Ratio | 2.37 | 1.98 | 0.81 | 0.32 | 2.11 | 5.43 |
| Quick Ratio | 12.68 | 12.77 | 8.80 | 3.64 | 2.96 | 66.81 |
| Current Ratio | 13.38 | 13.85 | 10.22 | 4.50 | 3.33 | 66.81 |
| Return on Equity (ROE) | -47.49% | -70.17% | -128.71% | -202.15% | -23.71% | |
| Return on Assets (ROA) | -29.46% | -41.87% | -69.40% | -96.34% | -30.20% | |
| Return on Capital Employed (ROCE) | -50.60% | -60.20% | -121.10% | -324.40% | -61.60% | -16.80% |
| Earnings Yield | -335.43% | -119.43% | -177.53% | -370.63% | -46.27% | -4.42% |
| FCF Yield | -204.46% | -103.38% | -178.07% | -395.77% | -111.16% | -3.37% |
| Buyback Yield / Dilution | -176.02% | -364.45% | -476.80% |